How SARS-CoV-2 “opens the floodgates” for neurological infection
Recent research indicates how COVID-19 can impact the brain and lead to multiple neurological symptoms. Research from Louisiana State University (LA, USA), presented at the virtual Experimental Biology 2021 meeting (27–30 April) by Ricardo Costa has revealed the pathway through which SARS-CoV-2 can infect the brain. Led by Diana Cruz-Topete, the research team believes that this evidence could explain why the neurological symptoms associated with COVID-19 can vary so dramatically in severity and prevalence. It is well understood that SARS-CoV-2 can infect the cells of the lungs by binding to the surface receptor ACE2. However, the presence of these receptors...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
